Patient Capital Management’s Vontier VNT Stock Holding History

Patient Capital Management’s Portfolio VNT Stock Details VNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-30,000	Closed	-$1.36M	–	44
2024 Q1	$1.36M	Sell	30,000 -10,000	-25%	-$390K	0.07%	40
2023 Q4	$1.38M	Hold	40,000	–	–	0.07%	40
2023 Q3	$1.24M	Hold	40,000	–	–	0.07%	40
2023 Q2	$1.29M	Hold	40,000	–	–	0.07%	41
2023 Q1	$1.09M	Hold	40,000	–	–	0.49%	41
2022 Q4	$773K	Sell	40,000 -25,000	-38%	-$469K	0.38%	43
2022 Q3	$1.09M	Sell	65,000 -131,800	-67%	-$2.94M	0.54%	38
2022 Q2	$4.52M	Buy	196,800 +52,100	+36%	+$1.34M	2%	22
2022 Q1	$3.67M	Sell	144,700 -17,100	-11%	-$452K	1.24%	34
2021 Q4	$4.97M	Buy	+161,800	New	+$5.27M	1.43%	30

Other funds holding VNT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Patient Capital Management's VNT Position: Q2 2024 in Review

Patient Capital Management sold out of Vontier (VNT) in Q2 2024, closing a stake of 30,000 shares — an estimated $1.36M sold.

Patient Capital Management first reported a position in VNT in Q4 2021 and held it in 10 quarters. The position peaked at $4.97M in Q4 2021. 480 funds tracked by Wall St. Rank hold VNT as of Q2 2024.

Patient Capital Management reported no remaining Vontier position as of Q2 2024 after selling out during the quarter.
Patient Capital Management sold 30,000 Vontier shares in Q2 2024, an estimated $1.36M.
Patient Capital Management first reported a position in Vontier in Q4 2021 and held it in 10 quarters.
Patient Capital Management's Vontier position peaked at $4.97M in Q4 2021.
480 funds tracked by Wall St. Rank held Vontier as of Q2 2024.

Based on Patient Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.